Axon Enterprise, Inc (NASDAQ:AXON) Shares Sold by Insigneo Advisory Services LLC

Insigneo Advisory Services LLC decreased its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 2.3% in the 1st quarter, HoldingsChannel reports. The firm owned 1,519 shares of the biotechnology company’s stock after selling 35 shares during the quarter. Insigneo Advisory Services LLC’s holdings in Axon Enterprise were worth $799,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Fourth Dimension Wealth LLC acquired a new stake in Axon Enterprise during the 4th quarter worth approximately $30,000. Elequin Capital LP acquired a new position in shares of Axon Enterprise in the fourth quarter worth $46,000. CoreFirst Bank & Trust purchased a new stake in shares of Axon Enterprise during the fourth quarter worth $59,000. Global Financial Private Client LLC raised its stake in shares of Axon Enterprise by 11,100.0% in the first quarter. Global Financial Private Client LLC now owns 112 shares of the biotechnology company’s stock valued at $59,000 after acquiring an additional 111 shares in the last quarter. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH acquired a new stake in shares of Axon Enterprise in the first quarter valued at $77,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on AXON shares. The Goldman Sachs Group boosted their target price on Axon Enterprise from $730.00 to $830.00 and gave the stock a “buy” rating in a research note on Wednesday, May 14th. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Bank of America upped their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a “buy” rating in a research note on Wednesday, June 4th. Barclays lifted their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an “overweight” rating in a research note on Friday, May 9th. Finally, Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. One research analyst has rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $699.55.

Insider Buying and Selling

In related news, CFO Brittany Bagley sold 3,400 shares of the company’s stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $700.00, for a total value of $2,380,000.00. Following the completion of the sale, the chief financial officer now directly owns 131,833 shares of the company’s stock, valued at $92,283,100. This represents a 2.51% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. This represents a 0.33% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 43,737 shares of company stock worth $29,797,795 in the last ninety days. 5.70% of the stock is owned by corporate insiders.

Axon Enterprise Price Performance

AXON stock opened at $777.54 on Wednesday. The business has a 50 day moving average price of $679.36 and a 200 day moving average price of $623.45. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68. The stock has a market cap of $60.53 billion, a price-to-earnings ratio of 187.81, a PEG ratio of 89.86 and a beta of 1.29. Axon Enterprise, Inc has a fifty-two week low of $279.02 and a fifty-two week high of $806.64.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The business had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. During the same quarter in the previous year, the firm earned $1.15 EPS. The company’s revenue was up 31.3% compared to the same quarter last year. Equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.